Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine

NCT03894969 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

541

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Disorders

Interventions

BIOLOGICAL: GSK's investigational non-typeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis (Mcat) multi-antigen vaccine (GSK3277511A) adjuvanted with AS01E
BIOLOGICAL: Shingrix GSK's lyophilized formulation of the herpes zoster (HZ) vaccine (GSK1437173A)

Sponsor

GlaxoSmithKline